Eleni built up a research group in close collaboration with LipoRegena GmbH in a nationally granted project focusing on adipose tissue as a source for clinically promising cell types. In this respect, she applies her knowledge about stem cells and overtook the responsibility for the evaluation of novel strategies for isolation, activation and characterization of adipose tissue-derived cell therapeutics. Moreover, in cooperation with the Red Cross Blood Transfusion Service of Upper Austria Linz she was responsible for the validation process and the GMP upgrade of stromal vascular fraction (SVF) isolation from adipose tissue (AGES approved).
Priglinger E, Strasser J, Buchroithner B, Weber F, Wolbank S, Auer D, Grasmann E, Arzt C, Sivun D, Grillari J, Jacak J, Preiner J, Gimona M (2021) Label-free characterization of an extracellular vesicle-based therapeutic. J Extracell Vesicles. 2021 Oct;10(12):e12156.
Priglinger E, Strohmeier K, Weigl M, Lindner C, Auer D, Gimona M, Barsch M, Jacak J, Redl H, Grillari J, Sandhofer M, Hackl M, Wolbank S (2020). SVF-derived extracellular vesicles carry characteristic miRNAs in lipedema. Sci Rep. 2020 Apr 29;10(1):7211.
Priglinger E, Maier J, Chaudary S, Lindner C, Wurzer C, Rieger S, Redl H, Wolbank S, Dungel P (2018). Photobiomodulation of freshly isolated human adipose tissue-derived stromal vascular fraction cells by pulsed light-emitting diodes for direct clinical application. J Tissue Eng Regen Med. 2018 Jun;12(6):1352-1362.
Priglinger E, Schuh CMAP, Steffenhagen C, Wurzer C, Maier J, Nuernberger S, Holnthoner W, Fuchs C, Suessner S, Rünzler D, Redl H, Wolbank S (2017). Improvement of adipose tissue-derived cells by low-energy extracorporeal shock wave therapy. Cytotherapy. 2017 Sep;19(9):1079-1095.